Table 2.
Virus only | Streptococcal ± virusc | |||||
---|---|---|---|---|---|---|
E/Ra | Flu | Corona-virusa | Otherb | Negatives | ||
No. patients at presentationa | 19 | 8 | 9 | 5 | 20 | 23 |
Symptom duration, median no. of days (IQR) | 3 (1) | 3 (0) | 3 (1) | 3 (0) | 2 (2) | 2 (1) |
Symptoms, n (%) | ||||||
Sore throatd | 19 (100) | 8 (100) | 9 (100) | 5 (100) | 20 (100) | 23 (100) |
Cough | 16 (84) | 8 (100) | 7 (78) | 4 (80) | 13 (65) | 15 (65) |
Fever | 12 (63) | 8 (100) | 3 (33) | 5 (100) | 18 (90) | 9 (39) |
Sneezing | 14 (74) | 6 (75) | 7 (78) | 4 (80) | 7 (35) | 7 (30) |
Runny nose | 18 (95) | 8 (100) | 7 (78) | 4 (80) | 13 (65) | 12 (52) |
Headache | 13 (68) | 7 (88) | 5 (56) | 5 (100) | 14 (70) | 13 (57) |
Sinus pain/pressure | 12 (63) | 7 (88) | 5 (56) | 3 (60) | 10 (50) | 8 (35) |
Cervical lymphadenopathy | 10 (53) | 6 (75) | 3 (33) | 3 (60) | 15 (75) | 13 (57) |
No. (%) prescribed antibiotic | 3 (16) | 0 (0) | 1 (11) | 1 (20) | 15 (75) | 8 (35) |
No. patients at one-week follow-up | 19 | 7 | 9 | 6 | 19 | 21 |
Symptom duration, median no. of days (IQR) | 4 (4) | 4 (2) | 7 (3) | 4 (2) | 3 (3) | 7 (3) |
No. (%) who missed ≥ 1 day of school | 5 (26) | 5 (71) | 4 (44) | 3 (50) | 13 (68) | 6 (29) |
Abbreviations: E/R Enterovirus/rhinovirus, IQR Interquartile range
aOne patient with co-infection of rhinovirus and coronavirus HKU1 was analyzed in both columns
bIncludes patients with adenovirus (n = 1), metapneumovirus (n = 2) and respiratory syncytial virus (n = 2)
cIncludes patients with group A (n = 17) and group C (n = 3) beta-hemolytic streptococci, with five and three viral co-infections, respectively. No group G beta-hemolytic streptococci were detected
dBy definition, this proportion is 100 % given study inclusion criteria